Product or Service

China Vine Tea Extract

Profile:Agent - Agent|Ref:PSL207656YH | Country: China | Currency: | Export: No

Currency :
incoterm : fob
country : China

Latin Name: Ampelopsis grossedentata W.T.Wang. Chinese name: Teng cha
Chemical name:
Product type: White powdered extract Part of the plant used: Leaves Extract method: Ethanol / water Effective components:Dihydromyricetin
Appearance: Fine whitish powder
Odour & Taste: Characteristic,special sour.
Molecular Formula: C15H12O8
Molecular Weight: 320.25
CAS No.:27200-12-0(Dihydromyricetin)
Boiling point: 780.7°C at 760 mmHg
Flash point: 296.7°C
Solubility: Good solubility in hot water ,ethanol and Acetone.
Vapor Pressure: 1.16E-25 mmHg at 25°C.
Vine tea, also be called as dragon-boat tea, dragon-whisker tea, young stem and leaf from Ampelopsis grossedentat , a plant of (Ampelopsis grossedentata)(Hand-Mazz), growing in 1300-1950m hillside shrub or valley woodland , always be consider as legendary healthy tea. Researches show than vine tea can relieve inflammatory, mixture cough and antitussives, it also has strong inhibitory effect to common bacteria can be found in food.
Some of flavonoids, for example Ampelopsin and Dihydromyricetin, are main active ingredients in vine tea, which have almost same MIC and MBC comparing with berberine, and have high Free radical scavenging activity varies between 73.3~91.5%. It can also reduce oxidative damage in the body, anti-aging, reduce the deformation and tissue necrosis of animal liver. Dihydromyricetin also have ability on lifting alcohol poisoning, prevent for AFL, Inhibit the deterioration of liver cells, decrease the incidence of liver cancer. In these case Dihydromyricetin is consider as a good product for enhance activity of SOD, protecting liver and removing inebriation. Dihydromyricetin now entered clinical trials as a class of new drugs when researcher of Dihydromyricetin achieved a major breakthrough in field of anti-leukemia and medicine of Nasopharyngeal cancer. Ampelopsis injection is expected to be a new treatment for leukemia and nasopharyngeal cancer.

Information Stock : Non Disponible en stock


No attachments

Contact the company